Adiuwantowa hormonoterapia u chorych na raka piersi
Author(s): ANNA BRZOZOWSKA, MARIA MAZURKIEWICZ
Adjuvant hormonal therapy should be a treatment of choice in breast cancer patients with positive level of receptors, both pre- and postmenopausal. Among available methods of hormonal therapy we can choose between antiestrogenic steroids, aromatase inhibitors and LH-RH analogs depending on hormonal status of patient, patients’s chronic diseases and their preferences. In this article, important questions regarding selection of hormonal manipulation, optimal sequence of different methods and duration of hormonal treatment will be discussed.
Share this article
Submitted PhD thesis in Biotechnology at GITAM University, Vizag.
The Past Head, General Administration of Pharmaceutical Care at Ministry of Health,
Saudi Arabia Critical Care/TPN
Clinical Pharmacist Ministry of Health,
Riyadh, Saudi Arabia.
Department of Radiation Oncology
Asahi University Hospital
Gifu city, Gifu, Japan
Maher Abdel Fattah Al-Shayeb
Department of Surgical Sciences, Ajman University, UAE
Institute of Gynecology and Obstetrics, Medical University of Lodz, I Clinic of Gynecology and Gynecological Oncology (Lodz, Poland)
Citations : 61
- Euro Pub
- Google Scholar
- Medical Project Poland
- Cancer Index
- Gdansk University of Technology, Ministry Points 20